bestrophin 1
Last updated 13 Mar 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The BEST1 gene provides instructions for making a protein called bestrophin-1, which appears to play a critical role in normal vision. Bestrophin-1 is found in a thin layer of cells at the back of the eye called the retinal pigment epithelium. This cell layer supports and nourishes the retina, which is the light-sensitive tissue that lines the back of the eye. The retinal pigment epithelium is involved in the growth and development of the eye, maintenance of the retina, and the normal function of specialized cells called photoreceptors that detect light and colour.
Video picks for GenesVideo library
Normal function
The BEST1 gene provides instructions for making a protein called bestrophin-1, which appears to play a critical role in normal vision. Bestrophin-1 is found in a thin layer of cells at the back of the eye called the retinal pigment epithelium. This cell layer supports and nourishes the retina, which is the light-sensitive tissue that lines the back of the eye. The retinal pigment epithelium is involved in the growth and development of the eye, maintenance of the retina, and the normal function of specialized cells called photoreceptors that detect light and colour.
Bestrophin-1 functions as a channel across cell membranes in the retinal pigment epithelium. Charged chlorine atoms (chloride ions) are transported through these channels in response to cellular signals. Some studies suggest that bestrophin-1 may also help regulate the entry of charged calcium atoms (calcium ions) into cells of the retinal pigment epithelium. Other potential functions of bestrophin-1 are under study.
Conditions referring to this gene or chromosome
Other names
BEST
BEST1_HUMAN
BMD
RP50
TU15B
vitelliform macular dystrophy 2 (Best disease, bestrophin)
VMD2
Patient picks for Genes

PID Q&A
Does PID cause bleeding?
Dr Sarah Jarvis MBE Symptoms may develop quickly. You can become quite ill over a few days. Sometimes symptoms are mild and develop slowly. For example, you may just have a mild abdominal pain that may 'grumble on' for weeks. In some cases no symptoms develop and you do not know that you are infected. However, you are still at risk of complications even if you have no symptoms at first. [https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1](https://patient.info/health/pelvic-pain-in-women/pelvic-inflammatory-disease#nav-1)
by Dr Sarah Jarvis

Asthma & COPD
How do I know if I have asthma?
Dr Sarah Jarvis MBE The common symptoms are cough and wheeze. You may also become breathless and develop a feeling of chest tightness. Symptoms can range from mild to severe between different people and at different times in the same person. Each episode of symptoms may last just an hour or so, or persist for days or weeks unless treated. [https://patient.info/health/asthma-leaflet#nav-1](https://patient.info/health/asthma-leaflet#nav-1)
by Dr Sarah Jarvis

Heart conditions
How to perform CPR
Without #CPR, your chance of dying dramatically increases after cardiac arrest. By learning CPR, you can become a hero and save someone else's life. Minutes spent learning CPR can mean a lifetime saved. The British Heart Foundation's RevivR campaign puts this power in your hands. Taking its free 15-minute online CPR course means you could be ready to act in an emergency: [https://revivr.bhf.org.uk/?_gl=1*fkc6u0*_gcl_au*ODQxNTE0NjAzLjE3MjM0NjU0MjM.*_ga*MTk4MDI3MTAyMC4xNzIzNDY1NDI0*_ga_L1TRS9RE0M*MTcyMzQ2NzQyOC4yLjAuMTcyMzQ2NzQyOC42MC4wLjA](https://revivr.bhf.org.uk/?_gl=1*fkc6u0*_gcl_au*ODQxNTE0NjAzLjE3MjM0NjU0MjM.*_ga*MTk4MDI3MTAyMC4xNzIzNDY1NDI0*_ga_L1TRS9RE0M*MTcyMzQ2NzQyOC4yLjAuMTcyMzQ2NzQyOC42MC4wLjA). Visuals: Ben Hudson

Risks of diabetes
What can someone with type 1 diabetes do to stop their glucose going too high?
Dr Sarah Jarvis MBE For more information on continuous glucose monitoring, go to [https://patient.info/health/type-1-diabetes/features/continuous-glucose-monitoring-in-type-1-diabetes](https://patient.info/health/type-1-diabetes/features/continuous-glucose-monitoring-in-type-1-diabetes)
by Dr Sarah Jarvis

Diabetes Q&A
What should you do if you have a hypo while driving?
Dr Sarah Jarvis If you have type 1 diabetes, you'll often be encouraged to control your blood sugar to almost the same levels as someone who doesn't have diabetes, especially if you're young and don't have complications of diabetes or other medical conditions. This is because high blood glucose in the long term is linked to damage to your kidneys, eyes, nerves, feet and heart. However, keeping tight control of your blood glucose does increase the risk of hypos. [https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous](https://patient.info/health/type-1-diabetes/features/how-low-blood-sugar-is-dangerous)
by Dr Sarah Jarvis

Other diabetes
Can athletes get diabetes?
Dr Sarah Jarvis MBE There are two main types of diabetes mellitus, which are called type 1 diabetes and type 2 diabetes. Type 1 usually first presents in children or in young adults. Type 2 is more associated with being overweight and most often first presents in people over the age of 40 years. However, type 2 diabetes is increasingly diagnosed in children and in young adults. For more information on diabetes, go to [https://patient.info/health/diabetes-mellitus-leaflet](https://patient.info/health/diabetes-mellitus-leaflet)
by Dr Sarah Jarvis
Related patient information and medicines

Patient information leaflet
Immunisation for flu
Influenza (flu) Flu is a common viral infection that tends to be most common in the winter. Flu can cause much more severe symptoms than the common cold Common cold. Some people can become seriously ill with flu, needing hospital treatment, and it can be life-threatening. Certain groups of people, such as older adults and young children, are at.

Patient information leaflet
Type 2 diabetes treatment
As soon as. ... leaflet that comes in the medicine packet for full details of cautions and possible side-effectsGLP-1 (glucagon-like peptide-1) mimetics - exenatide, dulaglutide, liraglutide, lixisenatide and semaglutide Exenatide Exenatide for diabetes , dulaglutide, lixisenatide Lixisenatide for diabetes , liraglutide Liraglutide for diabetes ,.

Patient information leaflet
Giant Cell Arteritis
One of the arteries that is commonly affected is the. (You have a temporal artery on each side of your head. They lie under the skin to the sides of the forehead - the temple area - and supply blood to this area). This is why the condition is also called temporal arteritis. Giant cell arteritis (temporal arteritis) causes No one really knows.

Patient information leaflet
Can I take Atorvastatin and Fibre supplements together?
Taking fibre supplements at the same time as atorvastatin can lower the amount of medicine your body absorbs. Our Medicines Interaction Checker helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Disclaimer This information is for general educational purposes only and should not be.

Patient information leaflet
Down's syndrome screening
This is so that you can have the combined test which is the recommended screening strategy in the first trimester of pre... What Down's syndrome screening tests are available? 10-14 weeks - combined test The standard test for Down's syndrome includes a combination of a nuchal translucency scan ( also called the NT scan - more details below) and a.

Patient information leaflet
Bupropion for quitting smoking
If you want to stop smoking, taking bupropion (trade name Zyban®) roughly doubles your chance of success. What is bupropion. Bupropion (Zyban®) Bupropion tablets for help stopping smoking is a medicine that was first developed to treat depression. It was found that it helped smokers to stop smoking. It seems to relieve the withdrawal symptoms that.
Further reading and references
- bestrophin 1; MedlinePlus, National Library of Medicine.
- Burgess R, MacLaren RE, Davidson AE, Urquhart JE, Holder GE, Robson AG, Moore AT, Keefe RO, Black GC, Manson FD. ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet. 2009 Sep;46(9):620-5. doi: 10.1136/jmg.2008.059881. Epub 2008 Jul 8.
- Burgess R, Millar ID, Leroy BP, Urquhart JE, Fearon IM, De Baere E, Brown PD, Robson AG, Wright GA, Kestelyn P, Holder GE, Webster AR, Manson FD, Black GC. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008 Jan;82(1):19-31. doi: 10.1016/j.ajhg.2007.08.004.
- Davidson AE, Millar ID, Urquhart JE, Burgess-Mullan R, Shweikh Y, Parry N, O'Sullivan J, Maher GJ, McKibbin M, Downes SM, Lotery AJ, Jacobson SG, Brown PD, Black GC, Manson FD. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet. 2009 Nov;85(5):581-92. doi: 10.1016/j.ajhg.2009.09.015. Epub 2009 Oct 22.
- Hartzell C, Qu Z, Putzier I, Artinian L, Chien LT, Cui Y. Looking chloride channels straight in the eye: bestrophins, lipofuscinosis, and retinal degeneration. Physiology (Bethesda). 2005 Oct;20:292-302. doi: 10.1152/physiol.00021.2005.
- Hartzell HC, Qu Z, Yu K, Xiao Q, Chien LT. Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol Rev. 2008 Apr;88(2):639-72. doi: 10.1152/physrev.00022.2007.
- Johnson AA, Lee YS, Chadburn AJ, Tammaro P, Manson FD, Marmorstein LY, Marmorstein AD. Disease-causing mutations associated with four bestrophinopathies exhibit disparate effects on the localization, but not the oligomerization, of Bestrophin-1. Exp Eye Res. 2014 Apr;121:74-85. doi: 10.1016/j.exer.2014.02.006. Epub 2014 Feb 19.
- Kramer F, White K, Pauleikhoff D, Gehrig A, Passmore L, Rivera A, Rudolph G, Kellner U, Andrassi M, Lorenz B, Rohrschneider K, Blankenagel A, Jurklies B, Schilling H, Schutt F, Holz FG, Weber BH. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet. 2000 Apr;8(4):286-92. doi: 10.1038/sj.ejhg.5200447.
- Marmorstein AD, Kinnick TR. Focus on molecules: bestrophin (best-1). Exp Eye Res. 2007 Oct;85(4):423-4. doi: 10.1016/j.exer.2006.03.021. Epub 2006 May 23. No abstract available.
- Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, Sandgren O, Forsman K, Holmgren G, Andreasson S, Vujic M, Bergen AA, McGarty-Dugan V, Figueroa D, Austin CP, Metzker ML, Caskey CT, Wadelius C. Identification of the gene responsible for Best macular dystrophy. Nat Genet. 1998 Jul;19(3):241-7. doi: 10.1038/915.
- Renner AB, Tillack H, Kraus H, Kohl S, Wissinger B, Mohr N, Weber BH, Kellner U, Foerster MH. Morphology and functional characteristics in adult vitelliform macular dystrophy. Retina. 2004 Dec;24(6):929-39. doi: 10.1097/00006982-200412000-00014.
- Renner AB, Tillack H, Kraus H, Kramer F, Mohr N, Weber BH, Foerster MH, Kellner U. Late onset is common in best macular dystrophy associated with VMD2 gene mutations. Ophthalmology. 2005 Apr;112(4):586-92. doi: 10.1016/j.ophtha.2004.10.041.
- Seddon JM, Afshari MA, Sharma S, Bernstein PS, Chong S, Hutchinson A, Petrukhin K, Allikmets R. Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy. Ophthalmology. 2001 Nov;108(11):2060-7. doi: 10.1016/s0161-6420(01)00777-1.
- Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):4008-13. doi: 10.1073/pnas.052692999.
- White K, Marquardt A, Weber BH. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies. Hum Mutat. 2000;15(4):301-8. doi: 10.1002/(SICI)1098-1004(200004)15:43.0.CO;2-N.
- Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, Perveen R, Reddy MA, Bhattacharya SS, Traboulsi E, Baralle D, De Laey JJ, Puech B, Kestelyn P, Moore AT, Manson FD, Black GC. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004 Oct;45(10):3683-9. doi: 10.1167/iovs.04-0550.
- Yu K, Qu Z, Cui Y, Hartzell HC. Chloride channel activity of bestrophin mutants associated with mild or late-onset macular degeneration. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4694-705. doi: 10.1167/iovs.07-0301.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

